Expression of lncRNAs in glioma: A lighthouse for patients with glioma

Glioma is the most common malignant tumour in the central nervous system, accounting for approximately 30 % of the primary tumours of this system. The World Health Organization grades for glioma include: Grade I (pilocytic astrocytoma), Grade II (astrocytoma, oligodastoma, etc.), Grade III (anaplast...

Full description

Bibliographic Details
Main Authors: Xiaolin Lu, Dongzhi Zhang
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024008302
_version_ 1797304528823910400
author Xiaolin Lu
Dongzhi Zhang
author_facet Xiaolin Lu
Dongzhi Zhang
author_sort Xiaolin Lu
collection DOAJ
description Glioma is the most common malignant tumour in the central nervous system, accounting for approximately 30 % of the primary tumours of this system. The World Health Organization grades for glioma include: Grade I (pilocytic astrocytoma), Grade II (astrocytoma, oligodastoma, etc.), Grade III (anaplastic astrocytoma, anaplastic oligodastoma, etc.) and Grade IV (glioblastoma). With grade increases, the proliferation, invasion and other malignant biological properties of the glioma are enhanced, and the treatment results are less satisfactory. The overall survival of patients with glioblastoma is less than 15 months. Recent research has focused on the roles of long non-coding RNAs, previously regarded as ''transcriptional noise'', in diseases, leading to a new understanding of these roles. Therefore, we conducted this review to explore the progress of research regarding the expression and mechanism of long non-coding RNAs in glioma.
first_indexed 2024-03-08T00:11:46Z
format Article
id doaj.art-0ba93a5a7f6b4ec4a62e8b5362dbc84e
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-08T00:11:46Z
publishDate 2024-02-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-0ba93a5a7f6b4ec4a62e8b5362dbc84e2024-02-17T06:38:41ZengElsevierHeliyon2405-84402024-02-01103e24799Expression of lncRNAs in glioma: A lighthouse for patients with gliomaXiaolin Lu0Dongzhi Zhang1Department of Orthopedic Surgery, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China; Corresponding author.Glioma is the most common malignant tumour in the central nervous system, accounting for approximately 30 % of the primary tumours of this system. The World Health Organization grades for glioma include: Grade I (pilocytic astrocytoma), Grade II (astrocytoma, oligodastoma, etc.), Grade III (anaplastic astrocytoma, anaplastic oligodastoma, etc.) and Grade IV (glioblastoma). With grade increases, the proliferation, invasion and other malignant biological properties of the glioma are enhanced, and the treatment results are less satisfactory. The overall survival of patients with glioblastoma is less than 15 months. Recent research has focused on the roles of long non-coding RNAs, previously regarded as ''transcriptional noise'', in diseases, leading to a new understanding of these roles. Therefore, we conducted this review to explore the progress of research regarding the expression and mechanism of long non-coding RNAs in glioma.http://www.sciencedirect.com/science/article/pii/S2405844024008302lncRNAGliomaMechanismBiomarker
spellingShingle Xiaolin Lu
Dongzhi Zhang
Expression of lncRNAs in glioma: A lighthouse for patients with glioma
Heliyon
lncRNA
Glioma
Mechanism
Biomarker
title Expression of lncRNAs in glioma: A lighthouse for patients with glioma
title_full Expression of lncRNAs in glioma: A lighthouse for patients with glioma
title_fullStr Expression of lncRNAs in glioma: A lighthouse for patients with glioma
title_full_unstemmed Expression of lncRNAs in glioma: A lighthouse for patients with glioma
title_short Expression of lncRNAs in glioma: A lighthouse for patients with glioma
title_sort expression of lncrnas in glioma a lighthouse for patients with glioma
topic lncRNA
Glioma
Mechanism
Biomarker
url http://www.sciencedirect.com/science/article/pii/S2405844024008302
work_keys_str_mv AT xiaolinlu expressionoflncrnasingliomaalighthouseforpatientswithglioma
AT dongzhizhang expressionoflncrnasingliomaalighthouseforpatientswithglioma